Results 151 to 160 of about 17,697 (207)

Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis [PDF]

open access: yes, 2015
Dieter Adam   +4 more
core   +1 more source

Targeting TNFR1-driven necroptosis in breast cancer. [PDF]

open access: yesEXCLI J
Rafeeq M   +7 more
europepmc   +1 more source

PANoptosis: a potential target of cardiomyopathy. [PDF]

open access: yesFront Immunol
Sun M, Lu C, Wei J, Gao C, Dong D.
europepmc   +1 more source

Resident alveolar macrophages are highly susceptible to the induction of RIPK1/RIPK3-mediated necroptosis which promote efficient pulmonary immune response. [PDF]

open access: yesCell Death Dis
Adachi T   +13 more
europepmc   +1 more source

Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1. [PDF]

open access: yesJ Exp Med
Liu R   +14 more
europepmc   +1 more source

SPOP mediates apoptosis and protects against necroptosis by regulating ubiquitination of RIPK1 and RIPK3. [PDF]

open access: yesJCI Insight
Ye Y   +8 more
europepmc   +1 more source

GADD45β inhibits RIPK3-mediated NF-κB activation by interfering with NEMO-RIPK1-RIPK3 interactions. [PDF]

open access: yesCell Death Discov
Casale C   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy